Immix Biopharma (IMMX) Accumulated Depreciation & Amortization (2023 - 2026)

Quarterly results put Accumulated Depreciation & Amortization at $384579.0 for Q1 2026, up 364.94% from a year ago — trailing twelve months through Mar 2026 was $384579.0 (up 364.94% YoY), and the annual figure for FY2025 was $320001.0, up 135.89%.

Immix Biopharma has reported Accumulated Depreciation & Amortization over the past 4 years, most recently at $384579.0 for Q1 2026.

  • Accumulated Depreciation & Amortization reached $384579.0 in Q1 2026 per IMMX's latest filing, up from $320001.0 in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $384579.0 in Q1 2026 and bottomed at -$891513.0 in Q4 2024.
  • Median Accumulated Depreciation & Amortization over the past 4 years was $14314.0 (2023), compared with a mean of -$39121.8.
  • The largest annual shift saw Accumulated Depreciation & Amortization tumbled 6328.26% in 2024 before it soared 803.83% in 2025.
  • Over 4 years, Accumulated Depreciation & Amortization stood at $14314.0 in 2023, then plummeted by 6328.26% to -$891513.0 in 2024, then soared by 135.89% to $320001.0 in 2025, then rose by 20.18% to $384579.0 in 2026.
  • Business Quant data shows Accumulated Depreciation & Amortization for IMMX at $384579.0 in Q1 2026, $320001.0 in Q4 2025, and $240888.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn -
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn -
5 Akari Therapeutics 605.66 Bn 605.66 Bn -
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn
8 Evaxion A 65.12 Bn 65.10 Bn -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn
10 Immix Biopharma 476.17 Mn 476.17 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 384,579.00
Mar 31, 2026 384,579.00
Dec 31, 2025 320,001.00
Dec 31, 2025 320,001.00
Sep 30, 2025 240,888.00
Sep 30, 2025 240,888.00
Jun 30, 2025 143,902.00
Jun 30, 2025 143,902.00
Mar 31, 2025 -145,156.00
Mar 31, 2025 -145,156.00
Dec 31, 2024 -891,513.00
Dec 31, 2024 -891,513.00
Sep 30, 2024 26,652.00
Sep 30, 2024 26,652.00
Jun 30, 2024 -241,982.00
Jun 30, 2024 -241,982.00
Mar 31, 2024 -296,339.00
Mar 31, 2024 -296,339.00
Dec 31, 2023 14,314.00
Dec 31, 2023 14,314.00
Mar 31, 2023 14,314.00
Mar 31, 2023 14,314.00